EP0521009A4 - Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent - Google Patents

Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent

Info

Publication number
EP0521009A4
EP0521009A4 EP19910905501 EP91905501A EP0521009A4 EP 0521009 A4 EP0521009 A4 EP 0521009A4 EP 19910905501 EP19910905501 EP 19910905501 EP 91905501 A EP91905501 A EP 91905501A EP 0521009 A4 EP0521009 A4 EP 0521009A4
Authority
EP
European Patent Office
Prior art keywords
hypotensive agent
ocular hypotensive
prostaglandin
trans
trans prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910905501
Other versions
EP0521009A1 (en
Inventor
David Frederick Woodward
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Allergan Inc
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of EP0521009A1 publication Critical patent/EP0521009A1/en
Publication of EP0521009A4 publication Critical patent/EP0521009A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
EP19910905501 1990-03-19 1991-02-12 Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent Withdrawn EP0521009A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49687990A 1990-03-19 1990-03-19
US496879 1990-03-19

Publications (2)

Publication Number Publication Date
EP0521009A1 EP0521009A1 (en) 1993-01-07
EP0521009A4 true EP0521009A4 (en) 1993-02-24

Family

ID=23974569

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910905501 Withdrawn EP0521009A4 (en) 1990-03-19 1991-02-12 Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent

Country Status (7)

Country Link
EP (1) EP0521009A4 (en)
JP (1) JPH05505605A (en)
CA (1) CA2076023A1 (en)
FI (1) FI924205A0 (en)
HU (1) HUT61666A (en)
IE (1) IE910865A1 (en)
WO (1) WO1991014428A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468778A (en) * 1992-09-24 1995-11-21 Allergan, Inc. Method of lowering intraocular pressure by administering a pharmaceutical composition containing 7-(5-substituted cyclopentyl) and 7-(5-substituted-cyclopentenyl) 5-heptenoic acids and derivatives
DE69311361T2 (en) * 1992-10-13 1998-01-08 Alcon Lab Inc COMPOSITIONS FOR TREATING GLAUCOMA CONTAINING PROSTAGLANDINES AND CLONIDINE DERIVATIVES
US6294563B1 (en) 1994-10-27 2001-09-25 Allergan Sales, Inc. Combinations of prostaglandins and brimonidine or derivatives thereof
US6414021B1 (en) * 2000-08-25 2002-07-02 Sucampo Ag Control of intraocular pressure during surgery
EP1545332B1 (en) 2002-10-04 2007-08-22 Tyco Healthcare Group Lp Tool assembly for surgical stapling device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2106534A1 (en) * 1970-09-15 1972-05-05 Upjohn Co
WO1989003384A1 (en) * 1987-10-07 1989-04-20 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2106534A1 (en) * 1970-09-15 1972-05-05 Upjohn Co
WO1989003384A1 (en) * 1987-10-07 1989-04-20 Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
INVEST. OPHTHALM. VISUAL SC. vol. 16, no. 12, December 1977, PHILADELPHIA pages 1125 - 1134 C. B. CAMRAS 'Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits.' *
See also references of WO9114428A1 *

Also Published As

Publication number Publication date
EP0521009A1 (en) 1993-01-07
WO1991014428A1 (en) 1991-10-03
CA2076023A1 (en) 1991-09-20
HU9202572D0 (en) 1992-12-28
IE910865A1 (en) 1991-09-25
FI924205A (en) 1992-09-18
JPH05505605A (en) 1993-08-19
HUT61666A (en) 1993-03-01
FI924205A0 (en) 1992-09-18

Similar Documents

Publication Publication Date Title
US5151444B1 (en) Ocular hypotensive agents
ES509900A0 (en) "A METHOD OF PREPARATION OF IMIDAZOLIDINONE DERIVATIVES".
AU6713287A (en) Expression of htlv-iii gag-gene
US5166178B1 (en) Ocular hypotensive agents
GR890100690A (en) Method for preparating ocular eyclosporine compositions
ZA902585B (en) Use of di-styryl-phenyl-triglycol ether as a crystallization inhibitor
CA2027351A1 (en) Emulsion of lipid containing a prostaglandin analogue
AU7850291A (en) Method of preparing foam using a partially fluorinated alkane
EP0521009A4 (en) Use of 5-trans prostaglandin f 2-g(a)? as an ocular hypotensive agent
DK0432441T3 (en) Process for preparing optically pure diastereoisomers of tetrahydrofolate compounds
EP0458903A4 (en) Soluble analogs of thrombomodulin
EP0331078A3 (en) Process for the preparation of optically active 4-oxo-1-benzopyran-2-carboxylic acid derivatives and intermediates thereof
CA2087425A1 (en) 2'-fluorofuranosyl derivatives and novel method of preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
DE68914273D1 (en) Working procedure of a timepiece.
GB8812488D0 (en) Derivatives of tetrahydrofuran & tetrahydrothiophen
AP9100278A0 (en) Heterocyclic anathracyclinone & anathracycline analogs
AR241021A1 (en) A PROCESS OF PREPARATION OF NEW DERIVATIVES OF 5- (OMEGA-FENITILAMIALQUIL) -4,5,6,7-TETRAHIDRO-TIENO- (3,2-C) -PIRIDINA "
GB2199828B (en) Synthesis of 2-(perfluoroalkyl)ethanethiols
GB8812487D0 (en) Derivatives of tetrahydrofuran & tetrahydrothiophen
AU520059B2 (en) "3-oxa bicyclo (3-1-0) hexan-2-one derivatives
EP0559894A4 (en) Novel use of alkanamidoammonium compound
AU618668B2 (en) Use of di-styryl-phenyl-triglycol ether as a crystallization inhibitor
AU1023292A (en) Heterocyclic amido prostaglandin analogs
RU1805188C (en) Masonъs scaffold
HU00018A9 (en) Use of 4-(hydroxydi-phenylmethyl)-1-piperidyl-phenylalkane derivatives for producing antihistamins

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19920910

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930106

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19941114

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19951017